Table. Population Characteristics.
| Characteristic | No. (%) | ||
|---|---|---|---|
| Anthracycline-Based | Gemcitabine-Based | Pazopanib | |
| No. of patients | 85 | 41 | 18 |
| INI-1 IHC statusa | |||
| Deficient | 59 (69) | 31 (76) | 17 (94) |
| Unavailable | 26 (31) | 10 (24) | 1 (6) |
| Age, median (range), y | 32 (15-77) | 34 (15-76) | 31 (15-67) |
| Sex | |||
| Male | 61 (72) | 26 (63) | 13 (72) |
| Female | 24 (28) | 15 (37) | 5 (28) |
| Primary siteb | |||
| Distal | 34 (40) | 20 (49) | 10 (56) |
| Proximal | 51 (60) | 21 (51) | 8 (44) |
| Histological type | |||
| Classic | 43 (51) | 23 (56) | 11 (61) |
| Proximal | 42 (49) | 18 (44) | 7 (39) |
| Stage | |||
| Locally advanced | 14 (17) | 1 (2) | 3 (16.7) |
| Locoregional lymphnodal involvement | 15 (18) | 7 (17) | 2 (11.1) |
| Metastatic | 56 (66) | 33 (81) | 13 (72.2) |
Abbreviations: IHC, immunohistochemistry; INI-1, integrase interactor 1.
a
By immunohistochemical analysis.
b
Distal primary sites: hand, forearm, foot. Proximal primary sites: head, neck, trunk, arm, axilla, thigh, groin, buttock, urogenitalia.